Share

|

|

|

Increasing measurable residual disease level predicts poorer AML outcomes

Research demonstrates a dose-dependent correlation between measurable residual disease and the likelihood of relapse and poor overall survival among adults with acute myeloid leukaemia who achieve complete remission before undergoing allogeneic haematopoietic cell transplantation. …more
Researchers have devised the Florida Scoring System to help clinicians stratify children with suspected Sjögren’s syndrome into three distinct classes, thereby improving diagnosis and disease monitoring. …more
Children diagnosed with spinal muscular atrophy through a newborn screening initiative have better functional outcomes than their peers diagnosed after the development of clinical symptoms, the SMARTCARE study findings show. …more
The glucagon-like peptide-1 receptor agonist lixisenatide slows motor disability progression in patients with early Parkinson’s disease, suggest findings from the LIXIPARK trial. …more
All articles loaded
No more articles to load

Don’t fall behind!

Get the latest headlines – in your specialties of choice – delivered straight to your inbox.

showcase

MEET THE SENIOR TEAM

Lynda Williams

medwireNews Deputy Bureau Chief